BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 37450109)

  • 1. Cell-Free RNA Sequencing from Biofluid Samples.
    Zhang L; Liu X; Wang C; Li X; Tian G; Wang W
    Methods Mol Biol; 2023; 2695():9-25. PubMed ID: 37450109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell-free RNA for the liquid biopsy of gastrointestinal cancer.
    Xing S; Zhu Y; You Y; Wang S; Wang H; Ning M; Jin H; Liu Z; Zhang X; Yu C; Lu ZJ
    Wiley Interdiscip Rev RNA; 2023; 14(5):e1791. PubMed ID: 37086051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Highly sensitive fusion detection using plasma cell-free RNA in non-small-cell lung cancers.
    Hasegawa N; Kohsaka S; Kurokawa K; Shinno Y; Takeda Nakamura I; Ueno T; Kojima S; Kawazu M; Suehara Y; Ishijima M; Goto Y; Kojima Y; Yonemori K; Hayashi T; Saito T; Shukuya T; Takahashi F; Takahashi K; Mano H
    Cancer Sci; 2021 Oct; 112(10):4393-4403. PubMed ID: 34310819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating cell-free nucleic acids and platelets as a liquid biopsy in the provision of personalized therapy for lung cancer patients.
    Sorber L; Zwaenepoel K; Deschoolmeester V; Van Schil PE; Van Meerbeeck J; Lardon F; Rolfo C; Pauwels P
    Lung Cancer; 2017 May; 107():100-107. PubMed ID: 27180141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Digital PCR-based evaluation of nucleic acid extraction kit performance for the co-purification of cell-free DNA and RNA.
    Deleu J; Schoofs K; Decock A; Verniers K; Roelandt S; Denolf A; Verreth J; De Wilde B; Van Maerken T; De Preter K; Vandesompele J
    Hum Genomics; 2022 Dec; 16(1):73. PubMed ID: 36587211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proof of concept: Detection of cell free RNA from EDTA plasma in patients with lung cancer and non-cancer patients.
    Mullins KE; Seneviratne C; Shetty AC; Jiang F; Christenson R; Stass S
    Clin Biochem; 2023 Aug; 118():110583. PubMed ID: 37182637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The clinical utility of cfRNA for disease detection and surveillance: A proof of concept study in non-small cell lung cancer.
    Metzenmacher M; Hegedüs B; Forster J; Schramm A; Horn PA; Klein CA; Bielefeld N; Ploenes T; Aigner C; Siveke JT; Schuler M; Lueong SS
    Thorac Cancer; 2022 Aug; 13(15):2180-2191. PubMed ID: 35708207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating cell-free messenger RNA enables non-invasive pan-tumour monitoring of melanoma therapy independent of the mutational genotype.
    Albrecht LJ; Höwner A; Griewank K; Lueong SS; von Neuhoff N; Horn PA; Sucker A; Paschen A; Livingstone E; Ugurel S; Zimmer L; Horn S; Siveke JT; Schadendorf D; Váraljai R; Roesch A
    Clin Transl Med; 2022 Nov; 12(11):e1090. PubMed ID: 36320118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluating the Effects of Storage Conditions on Multiple Cell-Free RNAs in Plasma by High-Throughput Sequencing.
    Sun J; Yang X; Wang T; Xing Y; Chen H; Zhu S; Zeng J; Zhou Q; Chen F; Zhang X; Wang WJ
    Biopreserv Biobank; 2023 Jun; 21(3):242-254. PubMed ID: 36006659
    [No Abstract]   [Full Text] [Related]  

  • 10. A comprehensive evaluation of full-spectrum cell-free RNAs highlights cell-free RNA fragments for early-stage hepatocellular carcinoma detection.
    Ning C; Cai P; Liu X; Li G; Bao P; Yan L; Ning M; Tang K; Luo Y; Guo H; Wang Y; Wang Z; Chen L; Lu ZJ; Yin J
    EBioMedicine; 2023 Jul; 93():104645. PubMed ID: 37315449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NGS Analysis of Liquid Biopsy (LB) and Formalin-Fixed Paraffin-Embedded (FFPE) Melanoma Samples Using Oncomine™ Pan-Cancer Cell-Free Assay.
    Olbryt M; Rajczykowski M; Bal W; Fiszer-Kierzkowska A; Cortez AJ; Mazur M; Suwiński R; Widłak W
    Genes (Basel); 2021 Jul; 12(7):. PubMed ID: 34356096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targets, pitfalls and reference materials for liquid biopsy tests in cancer diagnostics.
    Geeurickx E; Hendrix A
    Mol Aspects Med; 2020 Apr; 72():100828. PubMed ID: 31711714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analytical performance evaluation of a commercial next generation sequencing liquid biopsy platform using plasma ctDNA, reference standards, and synthetic serial dilution samples derived from normal plasma.
    Verma S; Moore MW; Ringler R; Ghosal A; Horvath K; Naef T; Anvari S; Cotter PD; Gunn S
    BMC Cancer; 2020 Oct; 20(1):945. PubMed ID: 33004033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor-Educated Platelet RNA and Circulating Free RNA: Emerging Liquid Biopsy Markers for Different Tumor Types.
    Hu H; Song H; Han B; Zhao H; He J
    Front Biosci (Landmark Ed); 2024 Feb; 29(2):80. PubMed ID: 38420812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating Cell-Free Nucleic Acids: Main Characteristics and Clinical Application.
    Szilágyi M; Pös O; Márton É; Buglyó G; Soltész B; Keserű J; Penyige A; Szemes T; Nagy B
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32957662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combining cell-free RNA with cell-free DNA in liquid biopsy for hematologic and solid tumors.
    Albitar M; Zhang H; Charifa A; Ip A; Ma W; McCloskey J; Donato M; Siegel D; Waintraub S; Gutierrez M; Pecora A; Goy A
    Heliyon; 2023 May; 9(5):e16261. PubMed ID: 37251903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The potential of liquid biopsies in gastrointestinal cancer.
    Wu C; Zhang J; Li H; Xu W; Zhang X
    Clin Biochem; 2020 Oct; 84():1-12. PubMed ID: 32540214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell-free DNA and next-generation sequencing in the service of personalized medicine for lung cancer.
    Bennett CW; Berchem G; Kim YJ; El-Khoury V
    Oncotarget; 2016 Oct; 7(43):71013-71035. PubMed ID: 27589834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A pilot study of next generation sequencing-liquid biopsy on cell-free DNA as a novel non-invasive diagnostic tool for Klippel-Trenaunay syndrome.
    Palmieri M; Pinto AM; di Blasio L; Currò A; Monica V; Sarno LD; Doddato G; Baldassarri M; Frullanti E; Giliberti A; Mussolin B; Fallerini C; Molinaro F; Vaghi M; Renieri A; Primo L
    Vascular; 2021 Feb; 29(1):85-91. PubMed ID: 32588787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Terminal modifications independent cell-free RNA sequencing enables sensitive early cancer detection and classification.
    Wang J; Huang J; Hu Y; Guo Q; Zhang S; Tian J; Niu Y; Ji L; Xu Y; Tang P; He Y; Wang Y; Zhang S; Yang H; Kang K; Chen X; Li X; Yang M; Gou D
    Nat Commun; 2024 Jan; 15(1):156. PubMed ID: 38168054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.